Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Roife

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2016
Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic Ductal AdenocarcinomaDavid Roife, Bingbing Dai, Ya'an Kang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 6, 2007
Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid PDarrell Pilling, David Roife, Min Wang, et al.
Clinical Breast Cancer|June 15, 2016
Do Socioeconomic Factors and Race Determine the Likelihood of Breast-Conserving Surgery?Bao C Nguyen, Zeinab M Alawadi, David Roife, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|August 8, 2009
A serum amyloid P-binding hydrogel speeds healing of partial thickness wounds in pigsRichard H Gomer, Darrell Pilling, Lawrence M Kauvar, et al.
Surgery|January 14, 2017
Generation of patient-derived xenografts from fine needle aspirates or core needle biopsyDavid Roife, Ya'an Kang, Li Wang, et al.
Surgery Open Science|May 13, 2021
Antineoplastic effects of auranofin in human pancreatic adenocarcinoma preclinical modelsMayrim V Rios Perez, David Roife, Bingbing Dai, et al.
Molecular Cancer Therapeutics|February 1, 2017
Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal AdenocarcinomaBingbing Dai, David Roife, Ya'an Kang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2014
Extracellular lumican inhibits pancreatic cancer cell growth and is associated with prolonged survival after surgeryXinqun Li, Mark A Truty, Ya'an Kang, et al.
Cell Death & Disease|July 11, 2021
Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathwayBingbing Dai, Jithesh J Augustine, Ya'an Kang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 9, 2014
Two-dimensional culture of human pancreatic adenocarcinoma cells results in an irreversible transition from epithelial to mesenchymal phenotypeYa'an Kang, Ran Zhang, Rei Suzuki, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2016
Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic Ductal AdenocarcinomaDavid Roife, Bingbing Dai, Ya'an Kang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 6, 2007
Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid PDarrell Pilling, David Roife, Min Wang, et al.
Clinical Breast Cancer|June 15, 2016
Do Socioeconomic Factors and Race Determine the Likelihood of Breast-Conserving Surgery?Bao C Nguyen, Zeinab M Alawadi, David Roife, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|August 8, 2009
A serum amyloid P-binding hydrogel speeds healing of partial thickness wounds in pigsRichard H Gomer, Darrell Pilling, Lawrence M Kauvar, et al.
Surgery|January 14, 2017
Generation of patient-derived xenografts from fine needle aspirates or core needle biopsyDavid Roife, Ya'an Kang, Li Wang, et al.
Surgery Open Science|May 13, 2021
Antineoplastic effects of auranofin in human pancreatic adenocarcinoma preclinical modelsMayrim V Rios Perez, David Roife, Bingbing Dai, et al.
Molecular Cancer Therapeutics|February 1, 2017
Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal AdenocarcinomaBingbing Dai, David Roife, Ya'an Kang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 23, 2014
Extracellular lumican inhibits pancreatic cancer cell growth and is associated with prolonged survival after surgeryXinqun Li, Mark A Truty, Ya'an Kang, et al.
Cell Death & Disease|July 11, 2021
Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathwayBingbing Dai, Jithesh J Augustine, Ya'an Kang, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 9, 2014
Two-dimensional culture of human pancreatic adenocarcinoma cells results in an irreversible transition from epithelial to mesenchymal phenotypeYa'an Kang, Ran Zhang, Rei Suzuki, et al.
Pageof 3